reversible modifications of cysteine thiols have a key role in redox signaling and regulation. a number of reversible redox modifications, including disulfide formation, s-nitrosylation (sno) and s-glutathionylation (ssG), have been recognized for their significance in various physiological and pathological processes. Here we describe a procedure for the enrichment of peptides containing reversible cysteine modifications. starting with tissue or cell lysate samples, all of the unmodified free thiols are blocked using n-ethylmaleimide (neM). this is followed by the selective reduction of those cysteines bearing the reversible modification(s) of interest. the reduction is achieved by using different reducing reagents that react specifically with each type of cysteine modification (e.g., ascorbate for sno). this protocol serves as a general approach for enrichment of thiol-containing proteins or peptides derived from reversibly modified proteins. the approach uses a commercially available thiol-affinity resin (thiopropyl sepharose 6B) to directly capture free thiol-containing proteins through a disulfide exchange reaction, followed by on-resin protein digestion and multiplexed isobaric labeling to facilitate liquid chromatography-tandem mass spectrometry (lc-Ms/Ms)-based quantitative site-specific analysis of cysteine-based reversible modifications. the overall approach requires a simpler workflow with increased specificity compared with the commonly used biotinylation-based assays. the procedure for selective enrichment and analyses of sno and the level of total reversible cysteine modifications (or total oxidation) is presented to demonstrate the utility of this general strategy. the entire protocol requires ~3 d for sample processing with an additional day for lc-Ms/Ms and data analysis.
IntroDuctIon
Protein cysteine residue is one of the most reactive amino acid residues in which the cysteine-free thiol serves as an electron donor in different reactions. Cysteine thiols in proteins not only frequently participate in enzymatic reactions, but also are subjected to a variety of covalent post-translational modifications (PTMs), which function as important mediators of redox signaling and regulation [1] [2] [3] [4] . The biological significance of several types of reversible cysteine PTMs has increasingly been recognized, including disulfide formation 5 , SNO 6, 7 , SSG 8 and S-sulfenylation (SOH) 9 , as well as the non-redox S-acylation (the reversible attachment of fatty acids through a thiol-ester group, mainly known as palmitoylation 10, 11 ). These reversible modifications have been found to modulate protein function in different biological pathways including gene transcription, metabolism, signal transduction, apoptosis, and protein trafficking and subcellular localization 3, 12, 13 . However, our overall knowledge of cysteine-based reversible modifications is still quite limited owing to the challenges associated with isolation, site-specific identification and quantification of these labile and dynamic modifications.
Traditionally, investigation of reversible cysteine modifications was most commonly performed via the biotin-switch technique (BST), an indirect approach initially developed for the detection of S-nitrosylated proteins 6, 14, 15 and other versions of modified BST. This technique has greatly advanced redox and Cys-PTMbased biology by extending its applications to other types of reversible modifications including SSG 16, 17 and reversible thiol oxidation 18 , as well as S-acylation 10, 11 . Typically, the BST and the modified BST consist of the following steps: (i) initial blocking of unmodified cysteine thiols by alkylation, (ii) selective reduction of modified cysteines (e.g., SNO), (iii) labeling of the reduced cysteines with reagents containing a biotin tag and (iv) enrichment of labeled proteins by avidin affinity purification for biochemical (e.g., western blotting) and proteomic analyses. When coupled with LC-MS/MS, those proteins that had been modified, as well as the specific cysteine residues at which the modifications occurred, can be identified 6, 19 . Although it is popular, the BST is labor intensive and often suffers from the issue of nonspecific binding during enrichment.
As an alternative, our laboratory has developed a resin-assisted approach for high-efficiency enrichment of cysteine-containing peptides using thiol-affinity resins 20, 21 . More recently, we and others [22] [23] [24] [25] [26] have demonstrated the effectiveness of enriching several types of reversibly modified cysteine thiols using this approach. Here we describe the detailed procedure for resin-assisted enrichment of thiols as a general strategy for site-specific profiling of multiple types of reversible cysteine modifications. Figure 1a illustrates the sample pre-processing options that mainly comprise blocking free thiols using NEM and selectively reducing the modified cysteines to free thiols by using different reducing reagents specific for each type of reversible modification. Figure 1b displays the overall workflow of enrichment and analysis after sample preprocessing. The workflow starts from direct capturing of derived free thiol-containing proteins onto the resin, followed by on-resin trypsin digestion, on-resin multiplex isobaric labeling using either 4-plex iTRAQ (isobaric tags for relative and absolute quantification) 27 or 6-plex TMT (tandem mass tags) 28 reagents and the final Resin-assisted enrichment of thiols as a general strategy for proteomic profiling of cysteine-based reversible modifications elution of the captured peptides. Labeled peptides are then subjected to LC-MS/MS for identification of specific modified cysteine residues and quantification of reversible modifications.
Compared with the BST, several advantages of the resin-assisted approach are notable. First, the resin-assisted procedure offers a simpler workflow than the biotin-avidin approach by facilitating the direct capture of thiol-containing proteins followed by on-resin tryptic digestion and on-resin isobaric labeling without the need of sample cleanup before the MS analysis (Fig. 1b) . In contrast, the BST requires the introduction of biotin tags to protein thiols before enrichment on an avidin column. The eluted proteins are then digested and peptides are subjected to cleanup before MS analysis. Second, the covalent capture process provides a higher enrichment specificity (with more than 95% of the final identified peptides as Cys-containing peptides) 23 and better sensitivity than avidin-based enrichment as demonstrated by a side-by-side comparison 22 . Finally, this approach is more effective for enabling MS-based site-specific identification and quantification of modified cysteine residues by allowing on-resin protein digestion and multiplex isobaric labeling 22, 23 . Therefore, this resin-assisted approach should have broad applications in redox and Cys-PTM-based biology by serving as a general enrichment strategy for multiple types of reversible cysteine redox modifications (e.g., SNO, SSG and total reversible oxidation) as well as S-acylation when coupled to selective reduction (Fig. 1) .
Experimental design
In this protocol, we describe the detailed procedure for the enrichment of thiols using a thiol-affinity resin (thiopropyl Sepharose 6B) as a general method for the enrichment of reversible cysteine modifications. The procedure is presented mainly in the context of analyzing SNO-modified peptides enriched from mouse muscle. The following aspects should be considered when adapting the protocol to specific applications. Different reversible cysteine modifications. For profiling different reversible cysteine modifications, the sample pre-processing procedure, including the blocking of free thiols and the selective reduction of specific types of reversible modifications (Figure 1a) , will need to be optimized. A number of previous reports have demonstrated selective reduction strategies for reversible cysteine modifications. For example, ascorbate is commonly used for reducing SNO 6, 23 , DTT for total oxidation 18, 26 (see Box 1 for a pre-processing procedure specific to total oxidation, i.e., total reversible cysteine modifications), glutaredoxin for SSG 29, 30 and hydroxylamine for S-acylation 10, 25 . Detailed conditions for selective reduction and possible negative or positive controls are listed in Supplementary  Table 1 . These strategies can be adapted and coupled with the resinassisted enrichment described here for profiling specific reversible modifications. Besides those modifications shown on Figure 1a , protein S-sulfhydration has recently been reported as a physiological redox modification; a modified version of the BST method was applied to detect proteins modified by S-sulfhydration 31 . In principle, our protocol is also applicable to S-sulfhydration; however, the blocking reagent methyl methanethiosulfonate (MMTS) was shown to react with both free thiols and persulfides 32 . Further studies are necessary in order to develop a specific blocking reaction scheme for this modification. Protein-level versus peptide-level enrichment. In principle, thiol-affinity enrichment can be performed at either the protein or peptide level. We have previously shown that both proteinand peptide-level enrichment provides comparable specificity and coverage of enriched cysteine-containing peptides 23 . In general, protein-level enrichment is simpler in its procedure; however, peptide-level enrichment has an advantage in terms of resin binding capacity. If a large amount of starting materials is desired for a given experiment or the proteins are difficult to dissolve in the required reaction volume for capture, the peptide-level enrichment may be preferred (see Box 2 for a procedure specific to peptide-level enrichment).
Analysis by western blotting instead of LC-MS. This enrichment protocol can also be used for western blotting applications to characterize specific cysteine-modified proteins by directly eluting the captured proteins from the resin.
Controls and replicates.
Controls tailored for the modification in question are often necessary in the study of specific reversible modifications. In the case of SNO, controls may include a negative control by SNO-specific UV photolysis 6, 33, 34 and a positive control treated with nitric oxide (NO) donors 15 . For other types of reversible modifications, similar control experiments should be performed (Supplementary Table 1 ). UV photolysis is considered to be a superior method for generating a negative control without introducing transition metals such as CuCl. Although the coupling of CuCl and ascorbate led to a more efficient reduction in SNO 23 , the addition of transition metals to the BST remains controversial owing to the potential of inducing artifacts 33, 34 . Biological replicates should also be included to ensure the confidence and consistency of the quantification. The multiplexed nature of isobaric labeling (iTRAQ or TMT) often facilitates the inclusion of several replicates in a single experiment. Incubate the samples in the dark at 37 °C at 850 r.p.m. in a Thermomixer for 1.5 h.  crItIcal step By adding cell lysis buffer that contains NEM to block all free thiols, oxidized cysteine-containing peptides can be enriched. By adding cell lysis buffer without NEM, total cysteine-containing peptides can be enriched. Make sure that NEM alkylation is performed at ~pH 7 for effective blocking of free thiols. Be sure to degas buffers by sonication, and always keep samples at 4 °C before NEM blocking. Minimize the amount of bubbles generated during cell lysis and protein extraction to reduce artificial oxidation of samples. Isotopic labeling strategy. For proteomic quantification of reversible modifications, different isotopic labeling strategies or labelfree quantification may be applied depending on the applications. On-resin multiplex isobaric labeling (iTRAQ) is presented here because of the convenience of on-resin amine-reactive labeling and the multiplexing capability. Mass spectrometers capable of detecting low-m/z-range reporter ions of iTRAQ are needed for this approach. Alternatively, one can apply other isobaric labeling techniques (e.g., TMT), stable isotope labeling by amino acids in cell culture (SILAC) 35 or label-free quantification 26 .
Limitations
Despite the advantages of this resin-assisted approach, its limitations are similar to those of the BST because of the nature of indirect detection for reversible PTMs. First, the efficiency and specificity of the free thiol blocking and selective reduction steps are crucial for the confident identification of modified cysteine peptides. It is nearly unavoidable that a small portion of the identified cysteine-containing peptides may be false positives for any given type of modification; for example, disulfide formation can be falsely identified as an SNO modification due to the imperfect specificity of ascorbate reduction 23 . However, well-designed controls (Supplementary Table 1 ) and reliable quantification can help to effectively distinguish such potential artifacts 34, 36, 37 . Second, the sensitivity of this approach may still not be sufficient for effective detection of low-abundance endogenous redox modifications (e.g., SNO) in cells or tissues. If necessary, a positive control with elevated levels of modifications (e.g., treated with NO donors for SNO) can be included in a multiplex quantification experiment to increase the coverage of reversibly modified cysteine sites 22, 23 . Despite the potential limitations, the resin-assisted approach represents a unique method for identifying novel cysteine sites sensitive to redox or other reversible modifications. Such discovery results could provide important guidance for functional studies of individual proteins by other orthogonal methods such as site-directed mutagenesis.
Box 2 | Peptide-level enrichment
The protocol can also be adapted for peptide-level enrichment. Instead of direct protein-level capture, proteins with their free thiols blocked are subjected to in-solution trypsin digestion at a ratio of 1:50 (wt:wt; trypsin:protein). After the peptide samples are transferred to the spin column containing the preconditioned resin (Step 20 in the PROCEDURE), peptides are selectively reduced using reducing reagents (e.g., ascorbate for SNO) and captured by the thiol-affinity resin. The enrichment protocol including pre-conditioning, selective reduction, washing, on-resin isobaric labeling and elution is essentially the same as the protein-level enrichment as described in the PROCEDURE. is necessary to obtain reporter ion intensity information 38 .
MaterIals
In our laboratory, we analyze peptide samples using an in-housedeveloped nanoLC system (or a commercially available nanoLC system such as Waters nanoAquity UPLC) coupled to an LTQ-Orbitrap Velos mass spectrometer via an electrospray ionization interface using chemically etched electrospray emitters (150-mm outer diameter × 20 mm) 39 . The experiment requires a reversed-phase C18 column (75-µm inner diameter and 20-40 cm long) containing 3-µm C18 particles. In our laboratory, the HPLC system consists of a custom configuration of 100-ml Isco Model 100DM syringe pumps, two-position Valco valves and a PAL autosampler 40 . For the experiment, operate the HPLC at a constant pressure (10,000 p.s.i.) with a gradient over the course of 100 min starting with 100% (vol/vol) of mobile phase A (0.1% (vol/vol) formic acid in nano-pure water) to 60% (vol/vol) of mobile phase B (0.1% (vol/vol) formic acid in ACN).
For MS analysis, record full MS spectra at a resolution of 30K (for ions at m/z 400) over the range of m/z 400-2,000 with an automated gain control (AGC) value of 1× 10 6 . The data-dependent acquisition mode is used for MS/MS with an AGC target value of 3 × 10 4 . Select the top six abundant parent ions for MS/MS using high-energy collisional dissociation with 40% normalized collision energy and a resolution of 7,500. Perform precursor ion activation with an isolation width of 2 Da, a minimal intensity of 500 counts and an activation time of 10 ms. Use a dynamic exclusion time of 45 s. proceDure preparation of protein samples • tIMInG 4-5 h 1| Cut frozen mouse quadriceps femoris muscle into four pieces, ~35 mg of wet weight for each piece.
2|
Wash the tissue by rinsing twice with cold PBS. Mince the muscle with a razor blade on a glass microscopy slide on ice.
3|
Transfer each piece of minced tissue into a 5-ml round-bottomed tube and homogenize the pieces in 500 µl of homogenization buffer at 13,000 r.p.m. for ~1 min, or until tissue is completely homogenized, using a tissue homogenizer. Transfer the homogenate into a new 1.5-ml microcentrifuge tube.
4|
Centrifuge the homogenate at 10,000g for 10 min at 4 °C, and transfer the supernatant into a new 1.5-ml microcentrifuge tube. Measure the protein concentration by using the BCA assay.
5| Dilute the muscle homogenates in SNO reaction buffer. Prepare four identical protein samples with 500 µg of protein in a 1-ml volume for each sample.  crItIcal step To minimize the photodecomposition of SNO during sample preparation, perform the above steps at 4 °C under restrained light.
6| (Optional) Induce SNO (Steps 6-8).
To induce SNO of proteins, add 10 µl of DMSO (control), 1 µl of 10 mM GSNO and 10 µl of 10 mM GSNO to three protein samples to obtain final concentrations of 0 µM, 10 µM and 100 µM GSNO, respectively. Incubate the samples at 37 °C with shaking at 800 r.p.m. for 30 min. Cool down the samples to 4 °C after incubation to stop the reaction and minimize the alteration of thiol modifications.  crItIcal step When endogenous SNOs are of interest, Steps 6-8 for inducing SNO can be omitted. The tissue can be directly homogenized in homogenization buffer, followed by immediately blocking free thiols by adding NEM and SDS to reach a final concentration of 100 mM NEM and 2% (vol/vol) SDS. You would then continue to Step 10.
7| Prepare a negative control by adding SNO reduction buffer (5 mM sodium ascorbate and 5 µM CuCl) to one protein sample. Note that sodium ascorbate/CuCl reduces endogenous SNO before NEM alkylation.  crItIcal step Negative control can also be generated by placing protein samples on ice in a 60-mm Petri dish with a 60-min exposure to a top-down UV transilluminator (365 nm) as previously described 6 or by incubating the samples ~2 cm from a 200-W UV-visible mercury vapor lamp for 3 min (~4 W of radiation from ~280-500 nm) 33 .
8|
Remove the excess GSNO by transferring the samples to 4-ml Amicon filters and by performing buffer exchange three times at 4 °C with a 4-ml total volume of cold water. Centrifuge the samples at 4,000g for 15-30 min each time at 4 °C. The final sample volume is ~50 µl in the Amicon filter.
Blocking free thiols by alkylation • tIMInG 2.5 h 9|
Add 500 µl of NEM blocking buffer to the samples. Incubate the samples in dark at 55 °C with shaking at 300 r.p.m. in a Thermomixer for 30 min.
10|
Remove the excess NEM by buffer exchange using 4-ml Amicon filters with 3 ml of 8 M urea three times and with 3 ml of cold water once. Each time the filter is centrifuged at 4,000g for 15-30 min at 4 °C. Concentrate the final sample to ~50 µl.  crItIcal step A complete removal of NEM is critical for enriching modified thiols. For samples with low levels of reduced thiol-containing proteins (e.g., endogenous S-nitrosylated proteins), acetone precipitation is recommended as an alternative method to completely remove excess NEM.
11|
Transfer the sample to a 0.6-ml microcentrifuge tube. Rinse the filter with 50 µl of 50 mM HEPES (pH 7.7) twice, and then combine the solution with the concentrated samples. Add 1 µl of 20% (wt/vol) SDS to the sample solution to reach a final SDS concentration of ~0.2%.  pause poInt The protein samples can be stored at −80 °C overnight.
pre-conditioning the thiopropyl sepharose resin • tIMInG 1 h 12| Weigh 35 mg of thiopropyl Sepharose 6B resin for each sample to be enriched; place the resin in a 1.5-ml tube.
13| Add 1 ml of water to each tube to rehydrate the resin for 15 min at room temperature.
14| Cut 5 mm off the end of a 1-ml pipette tip to make the hole larger for easier mixing. Use the modified pipette tip to resuspend the resin well, and leave the tubes for another 10 min at room temperature. Note that the resin swells and forms chunks after rehydration. The final volume of rehydrated resin is ~100 µl.
15|
Remove and discard the upper 0.5 ml of water. Carefully resuspend the settled resin and transfer the suspension to a 1-ml spin column using the modified tip.
16|
Place the spin column in a 2-ml receiving tube and centrifuge the tube at 1,000g for 30 s at room temperature to remove the water. Repeat this step by washing the resin five times with water and five times with coupling buffer.  crItIcal step To minimize the thiol oxidation, degas the coupling buffer by sonication for 20 min before starting the enrichment experiment.
17| Put the bottom plug and top cap on the spin column after the last wash. Keep the resin temporarily at 4 °C until the protein samples are prepared.  crItIcal step Be sure to resuspend the resin when washing with coupling or washing buffer.
selective reduction of sno • tIMInG 0.5 h 18| Centrifuge the samples (from Step 11) at 10,000g for 2 min at room temperature to remove any undissolved debris. Determine the protein concentration of the supernatant by the BCA assay. Adjust the volume of samples to ~100 µl with 50 mM HEPES (pH 7.7) so that protein concentrations are equal (400-500 µg) for each enrichment.
19| Add 500 mM sodium ascorbate and 500 µM CuCl to each protein sample to reach a final concentration of 5 mM sodium ascorbate and 5 µM CuCl.  crItIcal step As an alternative strategy, peptide-level enrichment can be performed. Before reducing protein samples with sodium ascorbate/CuCl, proteins can be digested into peptides, followed by SNO reduction for peptide-level enrichment (Box 2).  crItIcal step Note that the procedure described here is for the enrichment and identification of SNO modifications from mouse muscle treated with an NO donor as the primary example of profiling reversible cysteine modifications. Box 1 presents another example of the pre-processing procedure for enriching reversibly oxidized cysteines in RAW 264.7 cells.
enrichment of free thiol-containing proteins • tIMInG ~3 h 20|
Transfer each pre-processed (reduced) protein sample to the spin column that contains pre-conditioned resin with the bottom plug and top cap in place. Place each spin column into a 2-ml tube; incubate the tube at room temperature with shaking at 800 r.p.m. for 2 h.  crItIcal step Make sure that the bottom plug is tightly fitted in the column to prevent sample leakage during incubation with shaking. We recommend checking for any potential leakage after 5 min of incubation. ? trouBlesHootInG 21| Place the spin column into a new 1.5-ml tube with both top cap and bottom plug removed. Spin the column at 1,500g for 1 min at room temperature to collect the unbound portion (the proteins without free thiols or without formerly oxidized thiols).  crItIcal step The unbound portion can be used for a second enrichment to ensure that the resin capacity is sufficient for a complete enrichment.
22|
Thoroughly wash the resin five times with each of the enrichment washing buffers in the following order: first, 8 M urea; second, 2 M NaCl; third, 80% (vol/vol) ACN and 0.1% (vol/vol) TFA; and fourth, 25 mM HEPES. Use 0.5 ml of buffer for each wash, and replace both the top cap and bottom plug of the column after the last wash. The resin is washed 20 times in this step.  crItIcal step Make sure that you resuspend the resin during each wash step. Instead of on-resin digestion, the enriched proteins can be directly eluted (Step 32) for analyses using gel electrophoresis to evaluate protein-level enrichment and western blotting for measuring the levels of thiol modifications on a specific protein.
on-resin tryptic digestion • tIMInG 4 h 23| Add 120 µl of digestion buffer containing 25 mM HEPES buffer (pH 7.7), 0.1% (wt/vol) SDS, 1 mM CaCl 2 and 8 µg of trypsin to each spin column. Close the top cap and the bottom plug of each column. Incubate the column at 37 °C with shaking at 850 r.p.m. for 3 h.  crItIcal step This protocol is optimized using Promega Trypsin Gold. The digestion times may be different depending on the enzymes used. Digestion performance can be evaluated by eluting enriched peptides and running gel electrophoresis.
24|
Place the spin column into a new 1.5-ml tube with both the top cap and bottom plug removed, and spin it at 1,500g for 1 min at room temperature to collect the unbound portion (the non-cysteinyl peptides).
25|
Thoroughly wash the resin five times with each of the enrichment washing buffers in the following order: first, 8 M urea; second, 2 M NaCl; third, 80% (vol/vol) ACN and 0.1% (vol/vol) TFA; and fourth, 25 mM HEPES. Use 0.5 ml of buffer for each wash, and replace both the top cap and bottom plug of the column after the last wash.  crItIcal step The last wash should be free of primary or secondary amines (e.g., Tris), although tertiary or quaternary amines such as HEPES or TEAB are suitable as they are not reactive toward iTRAQ or TMT reagents. TEAB is the dissolution buffer for iTRAQ or TMT labeling, as per the manufacturer's instructions.  pause poInt Resin can be stored at 4 °C overnight.
on-resin isobaric labeling • tIMInG 3 h 26| Warm one set of manufacturer-provided iTRAQ reagents, anhydrous ethanol and dissolution buffer to room temperature.
27|
Add 70 µl of anhydrous ethanol to each iTRAQ reagent tube with gentle vortexing for 1 min. Spin the tubes at 1,000g for 10 s at room temperature to collect the reagents at the bottom of the tubes.
28|
Add 30 µl of manufacturer-provided dissolution buffer and 70 µl of iTRAQ reagents to each spin column. Close the top cap of the column. Incubate the column at room temperature with shaking at 850 r.p.m. for 1 h to label all peptides on the resin. ? trouBlesHootInG 29| Quench excess iTRAQ reagents by adding 8 µl of 5% (wt/wt) NH 2 OH in 200 mM TEAB to each column. Incubate the column at room temperature with shaking at 850 r.p.m. for 15 min.
30|
Place the spin column into a new 2-ml tube with both top cap and bottom plug removed, and spin the column at 1,500g for 1 min to remove the excess iTRAQ reagents. 33| Use 2-ml receiving tubes to collect the eluted cysteine-containing peptides at 1,500g for 1 min at room temperature with both the top cap and bottom plug removed.
34|
Replace the bottom plug of the column. Add another 100 µl of 20 mM DTT elution buffer to resin and mix with a pipette tip. Close the top cap of the column. Incubate the column at room temperature with shaking at 850 r.p.m. for 10 min. Collect the eluted peptides in the same receiving tube at 1,500g for 1 min with both top cap and bottom plug removed. Repeat this step once.  crItIcal step The resin tends to clump after DTT incubation because of its structural changes. We recommend using a pipette tip to stir the bead slurry after low-speed centrifugation. 42| Search the tandem mass spectra against a protein FASTA database (UniProt mouse database) using a database searching algorithm (e.g., Sequest) 41 . Set the key searching parameters as follows: 50 p.p.m. tolerance for precursor ion masses, 0.05 Da for fragment ion masses, a maximum of two missed tryptic cleavages, dynamic oxidation of methionine (+15.9949 Da), dynamic NEM modification of cysteine (+125.0477 Da) and static iTRAQ modification of lysine and N-termini (+144.1021 Da). Enable the decoy database searching to limit the final false discovery rate at the unique peptide level to <1% (refs. 42,43) . To filter peptide identifications, set the mass measurement error within 5 p.p.m., the mass spectrometry generating function (MS-GF) score 44 to <1 × 10 −8 for fully tryptic peptides and the MS-GF score to <1 × 10 −10 for partially tryptic peptides.
43|
Link the final identified MS/MS spectra with the iTRAQ reporter ion intensity data, and then group the data at the unique peptide level by summing the reporter ion intensities for all spectra that identify the same peptide.
? trouBlesHootInG Troubleshooting advice can be found in table 1.
• tIMInG 
antIcIpateD results
In a successful resin-assisted enrichment experiment, >95% of the final identified peptides should be cysteine-containing modified peptides because of the high specificity of this approach. The multiplexed quantification data that include negative or positive controls will allow the discrimination of redox-sensitive cysteine sites from potential artifacts. In the example of quantitative reactivity profiling of SNO in the mouse muscle (Fig. 2a) , the levels of SNO on individual cysteine sites induced by different doses of NO donors (i.e., 10 and 100 µM of GSNO) were quantified on the basis of the iTRAQ reporter ion intensities 23 . In this SNO reactivity profiling experiment, ~670 unique peptides were identified as potentially S-nitrosylated, covering 488 cysteine sites and 197 proteins. Figure 2b ,c depicts an example of MS/MS fragmentation of the identified SNO-modified peptide from sarcoplasmic/endoplasmic reticulum calcium ATPase 1 (SERCA1), and the corresponding increases in SNO levels in response to GSNO treatments are displayed as normalized reporter ion intensities. Notably, Cys-12 of SERCA1 was reported to be susceptible to oxidation 45 , and our findings confirmed the presence of SNO on Cys-12 and 15 other cysteines in SERCA1. Figure 3a shows another example of SNO in RAW 264.7 macrophage cells induced by different concentrations of CysNO. The displayed gel image of the eluted proteins enriched by this protocol confirms the specificity of the enrichment as evident by the low background of the untreated sample, the induction of SNO by CysNO, as well as the photolysis of SNO by UV exposure after SNO induction. In another experiment, this protocol was also applied for profiling the level of total oxidation on individual cysteine residues in which DTT was used to reduce all forms of reversibly oxidized thiols after the initial blocking of free thiols. The displayed gel image on Figure 3b confirms the increased levels of the final enriched oxidized cysteine-containing peptides (eluted from the resin after on-resin digestion and iTRAQ labeling) in response to diamide treatments. After LC-MS/MS analysis of iTRAQ-labeled peptides, the average stoichiometry of thiol oxidation across ~1,600 identified unique cysteine-containing peptides in this experiment (supplementary Data) was presented in Figure 3c . Our results (Fig. 3b,c) support the finding that the average level of thiol oxidation is relatively low in the untreated sample; however, it increases substantially with low doses of diamide treatments. The results are consistent with a recent report of in vivo thiol oxidation 46 . These results confirm the effectiveness of this enrichment method for profiling the level of total cysteine oxidation. Similarly, the utility of this protocol for profiling S-acylation has been recently demonstrated 25 . Taken together, these results clearly illustrate the specificity and efficiency of the resin-assisted thiol-affinity approach and its general utility for quantitative profiling of reversible modifications on cysteine thiols. 
